A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency

被引:143
作者
Emiliani, S
VanLint, C
Fischle, W
Paras, P
Ott, M
Brady, J
Verdin, E
机构
[1] NINCDS,VIRAL & MOLEC PATHOGENESIS LAB,NIH,BETHESDA,MD 20892
[2] NCI,MOLEC VIROL LAB,BETHESDA,MD 20892
关键词
D O I
10.1073/pnas.93.13.6377
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Study of the mechanism of HIV-1 postintegration latency in the ACH2 cell line demonstrates that these cells failed to Increase HIV-1 production following treatment with exogenous Tat, Reasoning that the defect in ACH2 cells involves the Tat response, we analyzed the sequence of tat cDNA and Tat responsive element (TAR) from the virus integrated in ACH2. Tat cDNA sequence is closely related to that of HIVLAI, and the encoded protein is fully functional in terms of long terminal repeat (LTR) transactivation, Cloning of a region corresponding to the 5'-LTR from ACH2, however, identified a point mutation (C-37-->T) in TAR. This mutation impaired Tat responsiveness of the LTR in transient transfection assays, and the measured defect was complemented in cells that had been treated with tetradecanoyl phorbol acetate or tumor necrosis factor type alpha (TNF-alpha). A compensatory mutation in TAR (G(28) --> A), designed to reestablish base pairing in the TAR hairpin, restored wild-type Tat responsiveness. When the (C-37 --> T) mutation was introduced in an infectious clone of HIV-1, no viral production was measured in the absence of TNF-alpha, whereas full complementation was observed when the infection was conducted in the presence of TNF-alpha or when a compensatory mutation (G(28) --> A) was introduced into TAR, These experiments identify a novel mutation associated with HIV-1 latency and suggest that alterations in the Tat-TAR axis can be a crucial determinant of the latent phenotype in infected individuals.
引用
收藏
页码:6377 / 6381
页数:5
相关论文
共 40 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   CELLULAR LATENCY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS WITH HIGH CD4 LEVELS CAN BE DETECTED BY THE PRESENCE OF PROMOTER-PROXIMAL TRANSCRIPTS [J].
ADAMS, M ;
SHARMEEN, L ;
KIMPTON, J ;
ROMEO, JM ;
GARCIA, JV ;
PETERLIN, BM ;
GROUDINE, M ;
EMERMAN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3862-3866
[3]   TRANS-ACTIVATOR GENE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) [J].
ARYA, SK ;
GUO, C ;
JOSEPHS, SF ;
WONGSTAAL, F .
SCIENCE, 1985, 229 (4708) :69-73
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA EXPRESSION BY 4 CHRONICALLY INFECTED CELL-LINES INDICATES MULTIPLE MECHANISMS OF LATENCY [J].
BUTERA, ST ;
ROBERTS, BD ;
LAM, L ;
HODGE, T ;
FOLKS, TM .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2726-2730
[5]   ANALYSIS OF ARGININE-RICH PEPTIDES FROM THE HIV TAT PROTEIN REVEALS UNUSUAL FEATURES OF RNA PROTEIN RECOGNITION [J].
CALNAN, BJ ;
BIANCALANA, S ;
HUDSON, D ;
FRANKEL, AD .
GENES & DEVELOPMENT, 1991, 5 (02) :201-210
[6]   ANALYSIS OF TAT FUNCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED LOW-LEVEL-EXPRESSION CELL-LINES U1 AND ACH-2 [J].
CANNON, P ;
KIM, SH ;
ULICH, C ;
KIM, SY .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1993-1997
[7]   CHARACTERIZATION OF A KISSING HAIRPIN COMPLEX DERIVED FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS GENOME [J].
CHANG, KY ;
TINOCO, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8705-8709
[8]   DISTINCT MODES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL LATENCY REVEALED BY SUPERINFECTION OF NONPRODUCTIVELY INFECTED CELL-LINES WITH RECOMBINANT LUCIFERASE-ENCODING VIRUSES [J].
CHEN, BK ;
SAKSELA, K ;
ANDINO, R ;
BALTIMORE, D .
JOURNAL OF VIROLOGY, 1994, 68 (02) :654-660
[9]  
CLOUSE KA, 1989, J IMMUNOL, V142, P431
[10]   ABSENCE OF SELECTION OF HIV-1 VARIANTS INVIVO BASED ON TRANSCRIPTION TRANSACTIVATION DURING PROGRESSION TO AIDS [J].
DELASSUS, S ;
MEYERHANS, A ;
CHEYNIER, R ;
WAINHOBSON, S .
VIROLOGY, 1992, 188 (02) :811-818